What is the FDA’s stance on cannabis, and how has it evolved? Join Darshan Kulkarni as he discusses recent FDA guidance on cannabis, and...
As more states pass cannabis supportive laws, companies often need to reevaluate how they approach cannabis use. Are your employees using...
Pharmacy has undergone a series of changes in 2019. What might this mean for the future of pharmacy? In this episode, Darshan talks about...
As more states move to decriminalize cannabis, the regulatory framework becomes more complicated. How can companies successfully navigate...
The FDA issued warning letters to several CBD companies for selling unapproved products with unsubstantiated medical claims.
The recent FDA hearing raised the the marketing of recreational CBD as a medical product--an act which falls in violation of federal and...